Kawashima Y, Aoki S, Takenaka H, Miyake Y
J Pharm Sci. 1984 Oct;73(10):1407-10. doi: 10.1002/jps.2600731021.
The spherically agglomerated crystals of aminophylline (theophylline-ethylenediamine complex) can be compounded directly into pharmaceutical formulations without further processing, e.g., granulation. Such crystals were prepared by mixing theophylline and ethylenediamine in a partially miscible solvent system, i.e., organic solvent-ethanol-water. The organic solvents used were chloroform, 1-hexanol, isopropyl acetate, isobutyl acetate, isoamyl acetate, benzene, toluene, n-hexane, or n-heptane. Spherical crystallization depended upon the solubility of theophylline in the solvent mixture. The resultant agglomerated crystals were identical with the theophylline-ethylenediamine complex by IR, X-ray, and differential scanning calorimetry analyses, and was the alpha-, beta-, or gamma-form when the water of crystallization was less than or equal to 0.5, 1.0, and 2.5 mol, respectively. When the amount of ethylenediamine used was less than 1.1 mL (0.0165 mol), the resultant agglomerated crystals were converted to anhydrous theophylline by washing with ethanol. When water was added to the system (greater than or equal to 0.3 mL, i.e., 0.0167 mol), water was occluded in the resultant agglomerates as water of crystallization. Ethylenediamine content in the agglomerated crystals could be controlled by changing the amount of ethylenediamine added in the crystallization solvent.
氨茶碱(茶碱 - 乙二胺复合物)的球形团聚晶体可直接配制成药物制剂,无需进一步加工,如制粒。此类晶体是通过在部分互溶的溶剂体系(即有机溶剂 - 乙醇 - 水)中混合茶碱和乙二胺制备的。所用的有机溶剂有氯仿、1 - 己醇、乙酸异丙酯、乙酸异丁酯、乙酸异戊酯、苯、甲苯、正己烷或正庚烷。球形结晶取决于茶碱在溶剂混合物中的溶解度。通过红外光谱、X射线和差示扫描量热法分析,所得团聚晶体与茶碱 - 乙二胺复合物相同,当结晶水分别小于或等于0.5、1.0和2.5摩尔时,为α - 、β - 或γ - 晶型。当所用乙二胺的量小于1.1 mL(0.0165摩尔)时,通过用乙醇洗涤,所得团聚晶体转化为无水茶碱。当向体系中加水(大于或等于0.3 mL,即0.0167摩尔)时,水作为结晶水被包藏在所得团聚物中。团聚晶体中的乙二胺含量可通过改变结晶溶剂中乙二胺的加入量来控制。